Australia markets closed

SomnoMed Limited (SOM.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2200+0.0150 (+7.32%)
At close: 04:10PM AEST

SomnoMed Limited

20 Clarke Street
Level 3
Crows Nest, NSW 2065
Australia
61 2 9467 0400
https://somnomed.com/au/

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

NameTitlePayExercisedYear born
Mr. Neil Verdal-Austin B.Com., C.A.Global CEO, MD & Director595.42kN/AN/A
Mr. Mark HardingVice President of Global Marketing433.44kN/AN/A
Mr. Matthew ConlonExecutive VP of Sales & Marketing - North America547.05kN/AN/A
Mr. Marco Van KleefVice President of Marketing & Sales - Europe493.89kN/AN/A
Mr. Darren Collins ACA, B CommChief Financial OfficerN/AN/A1969
Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FINCompany Secretary27.25kN/A1959
Mr. Christopher BedfordVice President of Global Production and Product Development228.4kN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Corporate governance

SomnoMed Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.